XML 47 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Goodwill and Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets  
Schedule of cost, accumulated amortization and carrying amount of intangible assets

March 31, 2025

December 31, 2024

Cost

Accumulated Amortization

Carrying Amount

Cost

Accumulated Amortization

Carrying Amount

Jornay

$

635,000

$

(48,199)

$

586,801

$

635,000

$

(27,242)

$

607,758

Belbuca

360,000

(228,063)

131,937

360,000

(209,214)

150,786

Nucynta Products

521,170

(451,940)

69,230

521,170

(438,094)

83,076

Symproic

70,000

(22,038)

47,962

70,000

(20,218)

49,782

Total intangible assets

$

1,586,170

$

(750,240)

$

835,930

$

1,586,170

$

(694,768)

$

891,402

Schedule of amortization expense recognized in cost of product revenues

Three Months Ended March 31,

2025

 

2024

Jornay PM

$

20,957

$

Belbuca

18,849

    

18,848

Nucynta Products

13,846

13,845

Symproic

1,821

1,824

Total amortization expense

$

55,473

$

34,517

Schedule of remaining amortization expense expected to be recognized

As of March 31, 2025, the remaining amortization expense expected to be recognized is as follows:

Years ended December 31,

Jornay

Belbuca

Nucynta Products

Symproic

Total

2025

$

62,872

$

56,544

$

41,538

$

5,465

$

166,419

2026

83,829

75,393

27,692

7,285

194,199

2027

83,829

7,285

91,114

2028

83,829

7,285

91,114

2029

83,829

7,285

91,114

Thereafter

188,613

13,357

201,970

Remaining amortization expense

$

586,801

$

131,937

$

69,230

$

47,962

$

835,930